Ankara Training and Research Hospital

Ankara 06340

0 studies enrolling now · 2 studies all time

What they study most

FSGS, Idiopathic Focal Segmental Glomerulosclerosis

Studies at this site

• A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB — Recruiting now
• Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria — Completed